Percutaneous Tracheostomy in Critically ill patients

CASE DISCUSSION

Percutaneous Tracheostomy in Critically ill patients

India flagPresented from India by Dr. Hazem Lashin

Views

9,304

Case Description

Percutaneous dilatational tracheostomy (PDT) is a commonly performed procedure in critically sick patients. It can be safely performed bedside by intensivists. This has resulted in decline in the use of surgical tracheostomy in intensive care unit (ICU) except in a few selected cases. Most common...

Case Summary

  • Percutaneous tracheostomy (perk trachi) is a surgical airway created by percutaneous serial dilation, maintained by a tracheostomy tube. It is considered when a patient requires mechanical ventilation for more than 7-10 days, aiming to reduce complications like tracheomalacia. Other indications include facilitating sedation reduction, prolonged ventilator weaning, and airway protection in patients with muscle disease or fluctuating consciousness.

Speaker Profile

Dr. Hazem Lashin

Dr. Hazem Lashin

FRCP FFICM FHEA PhD Consultant in Critical Care Medicine Faculty Tutor in Intensive Care Medicine Clinical Lead for High Dependency Unit Barts Heart Centre, St Bartholomew’s Hospital West Smithfield, London, EC1A 7BE
Dr. Hazem Lashin is a senior critical care physician serving as the Clinical Lead for the High Dependency Unit (HDU) at Barts Heart Centre, St Bartholomew's Hospital, part of Barts Health NHS Trust in West Smithfield, London, United Kingdom. He is also recognized as the Faculty Tutor for the Intensive Care Medicine training programme at Barts – one of the largest cardiac centres in Europe with over 56 ICU beds and more than 3,000 admissions annually. Barts Heart Centre is Europe's largest cardiac centre, offering highly specialized cardiothoracic ICM, ECMO services, and academic research opportunities including SSYs (Sub-Specialty Years) in Critical Care Echo and Education. Dr. Lashin's role involves both clinical leadership and the training and supervision of intensivists in cardiothoracic critical care.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.